Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jozef Škarda

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 6, 2012
Preventive effects of fluvastatin in rat mammary carcinogenesisPeter Kubatka, Nadežda Stollárová, Jozef Škarda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2026
Evaluation of DICER1 Immunohistochemistry as a Potential Surrogate for Mutation Status in Ovarian Sex Cord-Stromal TumorsKristýna Němejcová, Nikola Hájková, Michaela Kendall Bártů, et al.
Oncology Letters|August 20, 2019
Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbineMariam Gachechiladze, Tomáš Tichý, Vítězslav Kolek, et al.
Virchows Archiv : an International Journal of Pathology|January 22, 2025
Correlation between p53 immunoexpression and TP53 mutation status in extrapulmonary small cell neuroendocrine carcinomas and its association with patient survivalKlára Pavlíčková, Jan Hojný, Petr Waldauf, et al.
Virchows Archiv : an International Journal of Pathology|November 26, 2024
A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumorKristýna Němejcová, Nikola Hájková, Eva Krkavcová, et al.
Cell Communication and Signaling : CCS|October 1, 2024
Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitisMilan Kuchař, Kristýna Sloupenská, Leona Rašková Kafková, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated RadiotherapyZuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, et al.
Diagnostic Pathology|August 30, 2024
The role of stathmin expression in the differential diagnosis, prognosis, and potential treatment of ovarian sex cord-stromal tumorsAdam Šafanda, Michaela Kendall Bártů, Romana Michálková, et al.
Journal of Translational Medicine|May 6, 2024
Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imagingJoanna Maria Mierzwicka, Hana Petroková, Leona Rašková Kafková, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2025
Molecular and Immunohistochemical Classification of Extrapulmonary Small Cell Neuroendocrine Carcinomas: A Study of 181 CasesKlára Pavlíčková, Jan Hojný, Petr Waldauf, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 6, 2012
Preventive effects of fluvastatin in rat mammary carcinogenesisPeter Kubatka, Nadežda Stollárová, Jozef Škarda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2026
Evaluation of DICER1 Immunohistochemistry as a Potential Surrogate for Mutation Status in Ovarian Sex Cord-Stromal TumorsKristýna Němejcová, Nikola Hájková, Michaela Kendall Bártů, et al.
Oncology Letters|August 20, 2019
Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbineMariam Gachechiladze, Tomáš Tichý, Vítězslav Kolek, et al.
Virchows Archiv : an International Journal of Pathology|January 22, 2025
Correlation between p53 immunoexpression and TP53 mutation status in extrapulmonary small cell neuroendocrine carcinomas and its association with patient survivalKlára Pavlíčková, Jan Hojný, Petr Waldauf, et al.
Virchows Archiv : an International Journal of Pathology|November 26, 2024
A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumorKristýna Němejcová, Nikola Hájková, Eva Krkavcová, et al.
Cell Communication and Signaling : CCS|October 1, 2024
Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitisMilan Kuchař, Kristýna Sloupenská, Leona Rašková Kafková, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated RadiotherapyZuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, et al.
Diagnostic Pathology|August 30, 2024
The role of stathmin expression in the differential diagnosis, prognosis, and potential treatment of ovarian sex cord-stromal tumorsAdam Šafanda, Michaela Kendall Bártů, Romana Michálková, et al.
Journal of Translational Medicine|May 6, 2024
Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imagingJoanna Maria Mierzwicka, Hana Petroková, Leona Rašková Kafková, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2025
Molecular and Immunohistochemical Classification of Extrapulmonary Small Cell Neuroendocrine Carcinomas: A Study of 181 CasesKlára Pavlíčková, Jan Hojný, Petr Waldauf, et al.
Pageof 4